Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study.
Thirty patients with cystoid macular oedema secondary to chronic iridocyclitis were enrolled in a two period, prospective, randomised, double masked, crossover study that compared sustained release acetazolamide (500 mg twice a day) with a placebo to measure the effects on the reduction of cystoid m...
Guardat en:
| Publicat a: | Br J Ophthalmol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC504681/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8110697/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bjo.78.1.4 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|